CANOPY GROWTH CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.59 CAD | -1.61% |
|
-7.43% | +71.45% |
| 31/05 | Piper Sandler Reviews Canopy Growth's Q4 | MT |
| 30/05 | Transcript : Canopy Growth Corporation, Q4 2024 Earnings Call, May 30, 2024 |
| Sales 2024 | 344M 252M 21.05B | Sales 2025 * | 302M 221M 18.47B | Capitalization | 870M 638M 53.24B |
|---|---|---|---|---|---|
| Net income 2024 | -657M -482M -40.21B | Net income 2025 * | -166M -122M -10.16B | EV / Sales 2024 | 4.23 x |
| Net Debt 2024 | 394M 289M 24.1B | Net Debt 2025 * | 434M 318M 26.58B | EV / Sales 2025 * | 4.32 x |
| P/E ratio 2024 |
-1.33
x | P/E ratio 2025 * |
-6.16
x | Employees | 1,621 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.73% |
More Fundamentals
* Assessed data
More news
Latest transcript on Canopy Growth Corporation
More recommendations
More press releases
More news
| 1 day | -1.61% | ||
| 1 week | -7.43% | ||
| 1 month | -43.33% | ||
| 3 months | +161.04% | ||
| 6 months | +54.53% | ||
| Current year | +71.45% |
1 week
11.21
13.70
1 month
11.2117.79
Current year
3.7420.50
1 year
3.7426.00
3 years
3.74326.00
5 years
3.74716.00
10 years
3.74766.80
| Managers | Title | Age | Since |
|---|---|---|---|
David Klein
CEO | Chief Executive Officer | 60 | 01/18/01 |
Judy Hong
DFI | Director of Finance/CFO | 52 | 02/19/02 |
Tyler Burns
IRC | Investor Relations Contact | - | 01/16/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Klein
CEO | Chief Executive Officer | 60 | 01/18/01 |
David Lazzarato
CHM | Chairman | 69 | 31/20/31 |
Theresa Yanofsky
BRD | Director/Board Member | 67 | 31/20/31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/24/31 | 11.59 | -1.61% | 1,188,217 |
| 30/24/30 | 11.78 | +1.64% | 3,293,520 |
| 29/24/29 | 11.59 | +0.35% | 1,569,044 |
| 28/24/28 | 11.55 | -8.41% | 1,736,653 |
| 27/24/27 | 12.61 | +0.72% | 266,338 |
Delayed Quote Toronto S.E., May 01, 2024 at 01:30 am IST
More quotes
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.
Sector
Pharmaceuticals
Calendar
13/08/2024
- Q1 2025 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
14
Last Close Price
11.59
CAD
Average target price
7.371
CAD
Spread / Average Target
-36.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +71.45% | 638M | |
| +37.29% | 6.02B | |
| -21.28% | 4.19B | |
| +4.52% | 3.25B | |
| -18.16% | 2.87B | |
| -7.70% | 2.37B | |
| +41.50% | 1.89B | |
| -4.05% | 1.58B | |
| -15.56% | 1.54B | |
| -14.62% | 1.5B |
- Stock Market
- Equities
- WEED Stock
